Sex or Gender Reporting in Ophthalmology Clinical Trials Among US FDA, 1995 to 2022

This study attempts to evaluate the accuracy of sex and gender reporting and extent of sex- and gender-based analysis in clinical trials associated with US Food and Drug Administration drug approvals between January 1, 1995, and December 31, 2022.
Source: JAMA Ophthalmology - Category: Opthalmology Source Type: research